Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Plant-derived topoisomerase II inhibitors patented by Meiji Milk

March 10, 1999

Anticancer glycosidase inhibitors related to swainsonine

March 10, 1999

AN-207, a targeted cytotoxic compound with potential in treating prostate cancer

March 9, 1999

Licensing opportunity from Yeda: vitamin D3 analogue with multiple potential indications

March 9, 1999

BioNumerik initiates phase I clinical trials of promising new anticancer compound

March 9, 1999

Xenova reveals structure of P-gp-mediated MDR modulators, including clinical compound XR-9576

March 8, 1999

New anticancer agents from LG Chemical inhibit farnesyltransferase

March 8, 1999

Agouron solves structure of key target for drugs to block angiogenesis

March 8, 1999

Toagosei researchers identify potent antitumor MAb

March 5, 1999

MMP inhibitor-chemotherapeutic drug combination suppresses tumor dissemination in mice

March 5, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...